Motor-neuron-disease-like phenotype associated with IgLON5 disease

被引:0
作者
Sri Raghav Sista
Brian Crum
Albert Aboseif
Michelle F. Devine
Anastasia Zekeridou
M. Bakri Hammami
Mohammed M. Rezk
André Truffert
Patrice H. Lalive
Amy Kunchok
Andrew McKeon
Divyanshu Dubey
机构
[1] Mayo Clinic,Laboratory Medicine and Pathology, Department of Neurology
[2] Mayo Clinic,Department of Laboratory Medicine and Pathology
[3] University Hospital of Geneva,Division of Neurology, Department of Neurosciences, Faculty of Medicine
[4] Cleveland Clinic,Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute
[5] Mayo Clinic,Center for Multiple Sclerosis and Autoimmune Neurology
来源
Journal of Neurology | 2022年 / 269卷
关键词
IgLON5 autoimmunity; Motor neuron disease; Amyotrophic lateral sclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
A growing spectrum of neurological manifestations are being recognized in association with IgLON5 autoimmunity, including recent reports of motor-neuron-disease-like phenotype. Here we describe four cases of IgLON5 autoimmunity with motor neuron involvement and evaluate an additional 109 probable or definite amyotrophic lateral sclerosis cases seen in our neuromuscular clinic for IgLON5-IgG seropositivity. The presence of parasomnias, vocal cord dysfunction or hyperkinetic movements in a patient with motor-neuron-disease-like phenotype should prompt evaluation for IgLON5-IgG autoantibodies. Recognition and treatment of this autoimmune disease with immunosuppressive agents may bring about significant neurological improvement in a minority of cases.
引用
收藏
页码:6139 / 6144
页数:5
相关论文
共 13 条
  • [1] Landa J(2020)Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration Ann Neurol 88 1023-1027
  • [2] Sabater L(2014)A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study Lancet Neurol 13 575-586
  • [3] Gaig C(2019)Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease Curr Opin Neurol 32 493-499
  • [4] Compta Y(2017)Expanding the clinical spectrum of IgLON5-syndrome J Neuromuscul Dis 4 337-339
  • [5] Wenninger S(2017)IgLON5 antibody: neurological accompaniments and outcomes in 20 patients Neurol-Neuroimmunol Neuroinflamm 4 e385-543
  • [6] Honorat JA(2018)Motor neuron disease-like phenotype associated with anti-IgLON5 disease CNS Neurosci Ther 24 1305-180
  • [7] Tao QQ(2021)Anti-IgLON5 disease: a new bulbar-onset motor neuron mimic syndrome Neurology-Neuroimmunol Neuroinflamm 8 e692-undefined
  • [8] Werner J(2016)Neuropathological criteria of anti-IgLON5-related tauopathy Acta Neuropathol 132 531-undefined
  • [9] Gelpi E(2022)Case 1–2022: a 67-year-old man with motor neuron disease and odd behaviors during sleep N Engl J Med 386 173-undefined
  • [10] Videnovic A(2017)Understanding anti-IgLON5 disease Neurol Neuroimmunol Neuroinflamm 4 undefined-undefined